Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases

OBJECTIVE: Severe myelosuppression is a serious concern in the management of rheumatic disease patients receiving methotrexate (MTX) therapy. This study was intended to explore factors associated with the development of MTX-related myelosuppression and its disease severity. METHODS: We retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Shunsuke, Hidaka, Michihiro, Kawakita, Toshiro, Hidaka, Toshihiko, Tsuda, Hiroyuki, Yoshitama, Tamami, Migita, Kiyoshi, Ueki, Yukitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851368/
https://www.ncbi.nlm.nih.gov/pubmed/27128679
http://dx.doi.org/10.1371/journal.pone.0154744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851368/
https://www.ncbi.nlm.nih.gov/pubmed/27128679
http://dx.doi.org/10.1371/journal.pone.0154744

Ejemplares similares